Hashimoto Thyroiditis: Antibodies Explained & Tracked

TL;DR: Hashimoto is the most common cause of hypothyroidism in iodine-sufficient countries — 5 to 10 percent of women, 1 to 2 percent of men affected. Diagnostic combo: TPO above 100 IU/ml, often Tg above 115 IU/ml, plus hypoechoic ultrasound pattern. TRAb negative (otherwise Graves). Lab targets: TSH 1.0 to 2.0 mIU/l, fT3 and fT4 in the upper third of the normal range. Core interventions: 200 µg selenomethionine, vitamin D at 40 to 60 ng/ml, zinc 15 to 30 mg, stress reduction, L-thyroxine in overt hypothyroidism.

This article does not replace medical advice. Hashimoto belongs in endocrinology care. Never dose L-thyroxine yourself and do not stop a prescribed therapy on your own.

What Hashimoto Actually Is

Hashimoto thyroiditis is a chronic autoimmune disease. Your immune system produces antibodies against your own thyroid structures, mainly thyroid peroxidase (TPO) and thyroglobulin (Tg). Over years, these antibodies destroy thyroid tissue. The gland loses production capacity. The endpoint is hypothyroidism.

The course is not linear. It typically runs through three phases:

1. Euthyroid phase. Antibodies are positive, TSH, fT3 and fT4 still normal. Many patients already have symptoms — fatigue, brain fog, hair loss — even though values are labeled “fine”.
2. Subclinical hypothyroidism. TSH rises to 4.0 to 10 mIU/l, fT3 and fT4 stay in range. Around 5 percent of these cases develop overt hypothyroidism per year.
3. Overt hypothyroidism. TSH above 10 mIU/l, fT4 drops below range. L-thyroxine is now indicated.

In countries with sufficient iodine supply, Hashimoto is by far the most common cause of hypothyroidism. Women are affected roughly 5 times more often than men. The peak age is 30 to 50. For an overview of the full thyroid panel, read the thyroid values guide.

The 4 Key Antibodies

Hashimoto is not just about TSH. Antibodies are the key to diagnosis and to distinguishing other thyroid conditions.

Marker	Reference Range	Meaning in Hashimoto
TPO-Ab (thyroid peroxidase)	below 35 IU/ml	Lead antibody, positive in 90 % of Hashimoto patients
Tg-Ab (thyroglobulin)	below 115 IU/ml	Second Hashimoto marker, positive in 60 to 80 %
TRAb (TSH receptor)	below 1.75 IU/l	Negative in Hashimoto, positive in Graves
TSI (stimulating)	negative	TRAb variant, only positive in Graves

TPO-Ab is the most important marker. Below 35 IU/ml is normal. Between 35 and 100 IU/ml is borderline — often an early sign, sometimes nonspecific. Above 100 IU/ml makes Hashimoto very likely. Values above 1000 IU/ml are not rare and say little about severity. The trend matters more: does TPO drop under a selenium protocol? Does it stay stable? Does it rise under stress?

Tg-Ab complements the picture. Positive in 60 to 80 percent of Hashimoto patients, sometimes positive alone when TPO is borderline. When both TPO and Tg are positive, the diagnosis is nearly confirmed.

TRAb (TSH receptor antibodies) belong in the initial workup to rule out Graves disease. Graves causes hyperthyroidism, Hashimoto hypothyroidism — therapies are completely different. With Hashimoto, measure TRAb once at baseline. Repeated measurement is not needed.

A concrete example: Your values show TPO 480 IU/ml, Tg 180 IU/ml, TRAb negative, TSH 3.8 mIU/l, fT3 2.6 pg/ml, fT4 1.1 ng/dl. The pattern: Hashimoto in the early subclinical phase. In Lab2go you plot all five values in one trend and after 6 months of a selenium protocol see immediately how antibodies respond.

Symptoms: Why Early Detection Matters

Hashimoto symptoms are nonspecific — which is exactly why the diagnosis often gets missed for years. The most common complaints:

• Persistent fatigue and afternoon energy crashes
• Weight gain without dietary changes
• Hair loss, especially at the outer eyebrows
• Dry skin, brittle nails
• Feeling cold, cold hands and feet
• Constipation, slow digestion
• Depression, low drive, brain fog
• Muscle weakness, joint pain
• Menstrual irregularities
• Puffy face, especially in the morning

The tricky part: each symptom alone is harmless or has many other causes. Only the pattern plus positive antibodies makes the diagnosis. If three or more symptoms persist for months and you are a woman between 30 and 50, order TSH plus TPO antibodies. That is the simplest and most important first measurement.

Ultrasound: The Imaging Side

Antibodies are the lab side. Ultrasound is the imaging side. An experienced thyroid specialist often recognizes Hashimoto immediately by three signs:

• Hypoechoic structure. Healthy thyroid tissue is homogeneous and mid-bright on ultrasound. In Hashimoto it turns darker and uneven — the immune system has remodeled the tissue.
• Microcalcifications. Tiny bright dots in the tissue, a consequence of chronic inflammation.
• Volume change. Early Hashimoto can enlarge the gland (goiter), late Hashimoto shrinks it below 8 ml (women) or 12 ml (men).

Ultrasound does not replace antibodies — they complement each other. In unclear cases (borderline TPO, atypical symptoms) it tips the decision. Cost: 50 to 80 euros as a specialist out-of-pocket test.

Triggers: What Sets Off or Worsens Hashimoto

Hashimoto has a genetic component — HLA-DR3 and HLA-DR5 substantially raise risk. But genes alone are not enough. Epigenetic triggers decide whether and when the disease breaks out. The six main ones:

Iodine excess. High iodine doses (above 500 µg per day) clearly raise autoimmune activity. With Hashimoto, avoid iodine supplements above 150 µg per day and skip seaweed powder, high-dose potassium iodide and some sea algae products.

Selenium deficiency. Selenium is a cofactor of glutathione peroxidase, which protects the thyroid from oxidative stress. European soils are selenium-poor. Serum selenium below 80 µg/l is an independent risk factor.

Vitamin D below 30 ng/ml. Vitamin D modulates the immune system. Values below 30 ng/ml raise Hashimoto risk. Target: 40 to 60 ng/ml. The vitamin D3+K2 combo guide covers proper dosing.

Gut health. Leaky gut, elevated zonulin and gluten sensitivity are associated with Hashimoto. Evidence is not clear-cut but plausible: with barrier dysfunction, antigens enter the bloodstream and can trigger autoimmune processes.

Infections. Epstein-Barr virus (EBV), Yersinia enterocolitica and other pathogens are discussed as triggers. With positive TPO and persistent symptoms, serologic workup can make sense.

Hormonal transitions and chronic stress. Pregnancy, postpartum phase, perimenopause and chronically high cortisol shift the immune balance. Postpartum thyroiditis affects 5 to 10 percent of women after delivery and is often the first Hashimoto flare.

Selenium: The Best-Studied Supplement

Selenium is the first supplement intervention in Hashimoto. The evidence base is unusually solid for a dietary supplement.

Dosing. 200 µg selenomethionine per day for 3 to 6 months. Selenomethionine is the organic form, better absorbed and stored than sodium selenite.

Expected effect. The Gartner study (2002) and follow-ups show: TPO drops by 30 to 40 percent in about 50 percent of patients. The effect appears after 3 to 6 months. In the other half, values stay stable — which still beats a rise.

Myo-inositol combo. Nordio and Pajalich (2017) showed that 600 mg myo-inositol plus 83 µg selenomethionine per day lowers TSH and TPO more than selenium alone. Combination products with exactly this dosing are on the market.

Upper limit. Above 400 µg per day selenium becomes toxic (selenosis with hair loss, brittle nails, garlic breath). Stay below 200 µg per day long-term and test serum selenium annually. Target: 100 to 150 µg/l.

For more on combining with zinc and choosing the right form, see the zinc and selenium guide.

Vitamin D, Zinc and Other Supplements

Selenium is not the only tool. Three more building blocks belong in the base protocol:

Vitamin D (2,000 to 5,000 IU D3 plus K2). Hashimoto patients have above-average rates of vitamin D deficiency. Target: 25-OH vitamin D between 40 and 60 ng/ml. Dose depends on baseline. At 20 ng/ml you need 5,000 IU per day for 8 to 12 weeks, then retest. K2 (100 to 200 µg MK-7) complements D3.

Zinc (15 to 30 mg bisglycinate or picolinate). Zinc is a cofactor of deiodinases — the enzymes that convert T4 to active T3. Zinc deficiency measurably worsens conversion. Serum zinc reference: 70 to 120 µg/dl, target in the upper third.

Myo-inositol (600 mg). Combined with selenium. Improves insulin signaling and shows an additive effect on TSH and antibodies in studies.

LDN (low-dose naltrexone, 1.5 to 4.5 mg). Off-label, by prescription only. LDN modulates the immune system and is increasingly used in Hashimoto. Evidence base is limited but many patients report improvement in symptoms and antibodies. Ask your endocrinologist or an integrative physician.

Gluten-free: decide individually. Evidence is mixed. First test for celiac disease (tissue transglutaminase IgA). If positive, gluten avoidance is mandatory. If negative, run an 8-week trial: strict gluten-free, measure TPO and symptoms before and after. Decide based on data, not hype.

L-Thyroxine: When and How

In overt hypothyroidism, L-thyroxine (levothyroxine) is standard therapy. Rules of thumb:

• Starting dose: 25 to 50 µg in the morning on an empty stomach, 30 minutes before breakfast.
• Target dose: usually 1.6 µg per kg body weight for full replacement. A 70 kg person lands around 112 µg.
• Intake: always at the same time. Keep 4 hours distance from calcium, iron and coffee.
• Follow-up: TSH, fT3 and fT4 6 to 8 weeks after every dose change. Then every 6 months.

T4 alone or T4 plus T3? Standard therapy is L-thyroxine as pure T4. Some patients never feel well on it — often because of a conversion problem. Then a combination with T3 (liothyronine) or natural desiccated thyroid (NDT) can make sense. That decision belongs to the endocrinologist. Self-switching is dangerous.

A typical course: TSH at diagnosis 12 mIU/l, start with 50 µg L-thyroxine. After 8 weeks TSH 5.5 mIU/l, dose to 75 µg. After another 8 weeks TSH 2.1 mIU/l, fT3 3.2 pg/ml, symptoms clearly improved. Dose stable.

Pregnancy and Hashimoto

In pregnancy, targets are tighter. TSH should stay below 2.5 mIU/l in the first trimester and below 3.0 mIU/l in trimesters 2 and 3. L-thyroxine demand rises 25 to 50 percent from week 4 to 6 of pregnancy. Untreated hypothyroidism increases the risk of miscarriage, pregnancy complications and cognitive developmental issues in the child.

If you have Hashimoto and want to become pregnant, get TSH below 2.5 mIU/l before conception. During pregnancy, gynecologists and endocrinologists measure TSH every 4 to 6 weeks.

Tracking: How to Capture the Course Properly

Hashimoto is a long-term story. Single values say little — the trend over years shows whether your protocol works.

Every 3 months at therapy start: TSH, fT3, fT4. Once stable, stretch to every 6 months.

Annually: TPO, Tg, serum selenium, 25-OH vitamin D, zinc, ferritin. Ferritin matters because iron deficiency worsens thyroid function in parallel.

Every 2 years: thyroid ultrasound. More often if there are volume changes or nodules.

Record context with every measurement: current L-thyroxine dose, supplement stack, pregnancy, new symptoms, major stress phases. In Lab2go you see all markers in one trend and spot patterns you would miss in single values. More on methodology in the understanding blood values guide.

Hashimoto in Context with Other Markers

Hashimoto rarely stands alone. Three connections are especially relevant:

Hashimoto and inflammation. Chronic autoimmune activity can mildly raise CRP. If hs-CRP is above 2 mg/l, check triggers like gut health, micronutrient deficiencies and stress. More in the inflammation markers guide.

Hashimoto and iron. Ferritin below 70 ng/ml worsens T4-to-T3 conversion. Always check ferritin before raising L-thyroxine. Iron is often the missing piece.

Hashimoto and cortisol. Chronically high cortisol suppresses TSH and conversion. Under long-term stress, rT3 often rises and fT3 drops even though TSH looks normal.

Summary: Three Steps to Get Started

Hashimoto is chronic but manageable. With the right combination of diagnostics, supplements, therapy and tracking, you keep the disease stable.

1. Confirm the diagnosis. TSH, fT3, fT4, TPO, Tg, TRAb and thyroid ultrasound. Combined cost: 130 to 200 euros.
2. Start the base protocol. 200 µg selenomethionine, vitamin D at 40 to 60 ng/ml, zinc 15 to 30 mg, stress management. L-thyroxine under medical guidance if hypothyroid.
3. Track the trend. Thyroid panel every 3 to 6 months, antibodies and micronutrients annually. Document context.

Start today with logging in Lab2go and compare the plans and pricing. For baseline interpretation of your full labs, read the understanding blood values guide.

This article does not replace medical advice. Hashimoto belongs in specialist care. Never dose L-thyroxine yourself. Do not stop a prescribed therapy on your own — even if you feel well. Self-tracking complements medicine. It does not replace it.